🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12572+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12572 recruiting trials

Phase 2RecruitingNCT06005870

Zanubrutinib Combined With R-CHOP in the Treatment of Newly Diagnosed DLBCL With p53 Protein Expression

👨‍⚕️ Liling Zhang, M.D, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology📍 1 site📅 Started Nov 2022View details ↗
Phase 4RecruitingNCT05428826

Early Discontinuation of Steroid Treatment in Negative FDG-PET/CT Patients With Idiopathic Retroperitoneal Fibrosis

👨‍⚕️ Aline DECHANET, Assistance Publique - Hôpitaux de Paris (AP-HP)📍 15 sites📅 Started Nov 2022View details ↗
RecruitingNCT06785506

Multiple-biomarker Approach for Individualized Treatment of Heart Failure with Preserved Ejection Fraction

🏥 Erasmus Medical Center📍 6 sites📅 Started Nov 2022View details ↗
RecruitingNCT05522881

The Registry Study of Genetic Alterations of Oropharyngeal Cancer in Taiwan

👨‍⚕️ Pei-Jen Lou, MD, PhD, National Taiwan University Hospital📍 7 sites📅 Started Nov 2022View details ↗
RecruitingNCT05645510

LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study

🏥 University of Alberta📍 1 site📅 Started Nov 2022View details ↗
RecruitingNCT05548621

A Prospective Study to Evaluate the Implementation of Shared Decision Making Strategy for Renal Cell Cancer (RCC)

🏥 St. Antonius Hospital📍 1 site📅 Started Nov 2022View details ↗
NARecruitingNCT05911230

Advanced Diffusion MRI to Differentiate Tumor Recurrence From Pseudoprogression in Patients With Glioblastoma and Brain Metastases

👨‍⚕️ Dominik Cordier, PD Dr. med., University Hospital, Basel, Switzerland📍 1 site📅 Started Nov 2022View details ↗
Phase 2RecruitingNCT05917158

A Study of RC48-ADC Combined with JS001 for Postoperative Adjuvant Treatment of Upper Tract Urothelial Carcinoma

🏥 Jinling Hospital, China📍 1 site📅 Started Nov 2022View details ↗
Phase 1RecruitingNCT05652335

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

👨‍⚕️ Janssen Research & Development, LLC Clinical Trial, Janssen Research & Development, LLC📍 29 sites📅 Started Nov 2022View details ↗
NARecruitingNCT05579548

A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynziq® (Pegvaliase) During Pregnancy and Breastfeeding

👨‍⚕️ Medical Director, MD, BioMarin Pharmaceutical📍 4 sites📅 Started Nov 2022View details ↗
Phase 2RecruitingNCT05788679

A Study Using Subject-specific MRD to Adopt Treatment After HSCT for Subjects With MDS

👨‍⚕️ Magnus Tobiasson, PhD, Karolinska University Hospital📍 1 site📅 Started Nov 2022View details ↗
NARecruitingNCT04575883

HIIT in Youth With Congenital Heart Disease (MedBIKE)

👨‍⚕️ Michael Khoury, MD, University of Alberta📍 1 site📅 Started Nov 2022View details ↗
NARecruitingNCT05107154

iCARE 2.0: A Pilot Intervention of Dialectical Behavioural Therapy for Youth With Type 2 Diabetes.

👨‍⚕️ Brandy Wicklow, MD MSc, University of Manitoba📍 2 sites📅 Started Nov 2022View details ↗
RecruitingNCT05489549

Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers

👨‍⚕️ Justin L Grodin, MD MPH, UT Southwestern📍 3 sites📅 Started Nov 2022View details ↗
Phase 1, PHASE2RecruitingNCT05278208

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

👨‍⚕️ Margot Lazow, MD, Nationwide Children's Hospital📍 4 sites📅 Started Nov 2022View details ↗
NARecruitingNCT05561270

Light Exposure on Pain in Hypermobile Ehlers-Danlos Syndrome

👨‍⚕️ Philip Noto, DO, NYITCOM📍 1 site📅 Started Nov 2022View details ↗
Enrolling by InvitationNCT05763069

HOME: Home Monitoring of High-risk Pregnancies

👨‍⚕️ Anne Cathrine Staff, MD, PhD, Oslo University Hospital📍 1 site📅 Started Nov 2022View details ↗
NARecruitingNCT05326750

Non-invasive Neurostimulation as a Tool for Diagnostics and Management for Neurodegenerative Diseases

👨‍⚕️ Eino Solje, MD, PhD, Kuopio University Hospital📍 1 site📅 Started Nov 2022View details ↗
NARecruitingNCT05649072

Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.

👨‍⚕️ Arun Banu, MD, M.D. Anderson Cancer Center📍 1 site📅 Started Nov 2022View details ↗
RecruitingNCT05402813

Natural History in Children up to 16 Years With Mild to Profound Hearing Loss Due to Mutations in GJB2 / OTOF Genes

👨‍⚕️ Natalie LOUNDON, MD, Necker Hospital📍 1 site📅 Started Nov 2022View details ↗
← PreviousPage 444 of 629Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →